Volver a Agenda
Session Chair(s)
Kenneth I. Kaitin, PHD
Professor and Senior Fellow
Tufts Center for the Study of Drug Development, United States
Learning Objective : Identify shifts in pharmaceutical R&D; Discuss the impact of these changes on the R&D landscape; Examine the ramifications of industry's shift to targeted and precision medicines in the discovery, development, and commercialization of new medical products.
Speaker(s)
Panelist
Kenneth Getz, MBA
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Panelist
Scott M. Whitcup, MD
Allergan, Inc., United States
Chief Scientific Officer
Panelist
Alberto Grignolo, PHD
DIA Global Forum, United States
Editor-in-Chief
Panelist
Michael James Doherty
Foundation Medicine, United States
Head of Product Development
¿Tiene una cuenta?